Granata Bio Corporation, a biopharma company dedicated to improving women’s health and addressing infertility challenges, has successfully raised $15 million in its Series A+ funding round. The funding round was exclusively supported by existing investors, including prominent partners Gedeon Richter, CooperSurgical, Amboy Street Ventures, and other strategic investors. With this round, Granata Bio has raised over $30 million to date.
The investment will help Granata Bio further develop its existing pipeline and explore new innovative assets within the reproductive health sector. The company aims to enhance its leadership in this space by identifying and advancing novel therapeutic solutions for fertility patients.
Evan Sussman, CEO of Granata Bio, expressed appreciation for the ongoing support, highlighting the role of strategic partners like Gedeon Richter and CooperSurgical, both leaders in women’s health. “Granata Bio is committed to improving access for fertility patients by identifying and developing new therapeutic solutions. With this new funding, we are well-positioned to accelerate the development of our current and future pipeline,” Sussman said.
Granata Bio was represented by Mintz in the funding round.
About Granata Bio Founded in 2018, Granata Bio is a US-based biopharma company focused on women’s health and infertility. Its pipeline includes collaborations spanning multiple IVF product classes, aiming to make a significant impact on the fertility treatment landscape.
About Gedeon Richter Gedeon Richter Plc, headquartered in Budapest, Hungary, is a major pharmaceutical company with an expanding global presence. The company is highly regarded for its research in women’s healthcare and its development of biosimilars for various diseases, including osteoporosis and rheumatoid arthritis.
About CooperSurgical CooperSurgical is a leading company in fertility and women’s healthcare, specializing in assisted reproductive technology (ART) and genomic solutions. The company offers over 600 clinically relevant medical devices, supporting ART professionals and providing innovative solutions for families. CooperSurgical is a wholly-owned subsidiary of CooperCompanies, based in Trumbull, Connecticut.
Related topics:
Ethical Questions Arise Over Fertility Doctor’s Practices After DNA Discovery
AI Tool Developed to Predict IVF Success in Men with Y Chromosome Microdeletion
How Air Pollution Threatens the Success of IVF According to a New Study
